Anyone with an existing inventory of the product should quarantine the recalled lot immediately.Customers who purchased the impacted product directly from Glenmark and consumers can call Qualanex at Consumers who have Ranitidine Tablets, USP subject to this recall Consumers who would like to report any adverse reactions or quality problems experienced as a result of their use of this product, or have questions regarding the use of Ranitidine Tablets, USP can contact Glenmark Drug Safety by phone at Glenmark customer service center at 1-888-721- 7115, Monday thru Friday, 9:00 am – 6:00 pm, US EST, or e-mail at Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.November 19, 2019 -- Precision Dose Inc. is voluntarily recalling 5 lots of Ranitidine is a histamine-2 blocker, which decreases the amount of acid created by the stomach. Wholesalers (direct customers) will be asked to immediately stop distribution and return any stock to Sandoz, and contact the retail pharmacies in their group to do the same.

Appco is arranging for return of all recalled products to ANI Pharmaceuticals, Inc. Run through your list of current meds with your doctor and pharmacist to see if anything you are taking is currently contributing. Glenmark recalled 928 unexpired lots of ranitidine 150 mg and 300 mg tablets on Dec. 17, 2019. (CNN) The US Food and Drug Administration is requesting that manufacturers pull all prescription and over-the-counter ranitidine drugs, known by the brand name Zantac… Ranitidine tablets, 150 mg and 300 mg, and ranitidine syrup 15 mg/mL. MedWatch Safety Alerts are distributed by the FDA and published by Drugs.com. The affected Ranitidine Hydrochloride Tablets can be identified by NDC numbers stated on the product label.The affected Ranitidine Hydrochloride Tablets were distributed Nationwide to Warehousing Chains. When SELF reached out to the FDA for comment, they declined an interview but responded with text included in their “FDA is not recommending individuals stop taking all ranitidine medicines at this time,” If you were only taking ranitidine occasionally, you could switch to another H2 blocker, If you were taking heartburn drugs with ranitidine more than twice a week, a different class of medications than H2 blockers may actually make more sense for you. Pharmacies will be asked to immediately stop dispensing Sandoz Ranitidine Hydrochloride Capsules and return remaining stock to Sandoz by contacting Stericycle to request a recall packet. Denton Pharma repackaged these lots and distributed them to Northwind Pharmaceuticals LLC and Crosswind Pharmacy.On Jan. 7, 2020, Appco recalled 8 lots of its ranitidine 150 mg and 300 mg capsules. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.Perrigo is notifying our retail customers by phone, email or other communication with recall notification communications to arrange for the return of all recalled product.Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.Perrigo Company plc is dedicated to making lives better by bringing high quality and affordable selfcare products that consumers trust everywhere they are sold.

No reports of injury or adverse events to date.Ranitidine is used as a short-term treatment for active duodenal ulcers, maintenance therapy for duodenal ulcer patients, treatment of pathological hypersecretory conditions, short-term treatment of active, benign gastric ulcers, maintenance therapy for gastric ulcers, treatment of GERD and treatment of endoscopically diagnosed erosive esophagitis.Product was distributed Nationwide to Wholesalers for use in hospital settings.American Health Packaging has notified its distributors by recall letter, sent November 1st, 2019, to immediately discontinue distribution of the specific lots being recalled and to notify their sub-accounts. Apotex said it sent a notification letter to the warehousing chains and is arranging the return of all recalled products. Several lots tested from different manufacturers contained NDMA levels higher than the recommended daily limit of 0.32 ppm.“The FDA conducted thorough laboratory tests and found NDMA in ranitidine at low levels,” the agency said about its earlier tests.

“Stomach acid levels go right back to baseline…so they’re not very good medicines to be on long-term.” (They’re better for short-term situations like after Thanksgiving dinner, Dr. Gabbard says. On Jan. 6, 2020, Northwind Pharmaceuticals announced its recall of ranitidine 150 mg and 300 mg tablets.

Select one or more newsletters to continue. The recall impacts drugs sold in the United States and Canada. New FDA studies also confirmed significant increases in NDMA levels when samples were stored at higher temperatures. The product can be identified by checking the product name, count/bottle, manufacturer details and batch or lot number on the bottle containing these products.Ranitidine Capsules 150 mg & Ranitidine Capsules 300 mg were distributed nationwide.Appco is notifying their marketing partner (ANI Pharmaceuticals, Inc.) by phone, email or other communication with recall notification communication. Any information published on this website or by this brand is not intended as a substitute for medical advice, and you should not take any action before consulting with a healthcare professional.All the best health and wellness advice, tips, tricks, and intel, delivered to your inbox every day.